about
Association of Fatigue With Sarcopenia and its Elements: A Secondary Analysis of SABE-Bogotá.A Frailty Index from Next-of-Kin Data: A Cross-Sectional Analysis from the Mexican Health and Aging Study.Frailty prevalence and associated factors in the Mexican health and aging study: A comparison of the frailty index and the phenotype.Economic burden to primary informal caregivers of hospitalized older adults in Mexico: a cohort study.Handgrip strength predicts functional decline at discharge in hospitalized male elderly: a hospital cohort study.Clinimetric testing in mexican elders: associations with age, gender, and place of residenceAssessing the Validity of Self-Rated Health with the Short Physical Performance Battery: A Cross-Sectional Analysis of the International Mobility in Aging Study.RISK FACTORS FOR SLOW GAIT SPEED: A NESTED CASE-CONTROL SECONDARY ANALYSIS OF THE MEXICAN HEALTH AND AGING STUDYMortality as an adverse outcome of sarcopenia.Late-life depressive symptoms: prediction models of changeCancer and frailty in older adults: a nested case-control study of the Mexican Health and Aging StudyFactors associated with help-seeking behaviors in Mexican older individuals with depressive symptoms: a cross-sectional study.Calf circumference predicts mobility disability: A secondary analysis of the Mexican health and ageing study.Availability and use of dual energy X-ray absorptiometry (DXA) and bio-impedance analysis (BIA) for the evaluation of sarcopenia by Belgian and Latin American geriatricians.Fatigue: Relevance and implications in the aging population.Validity of Knee-Estimated Height to Assess Standing Height in Older Adults: A Secondary Longitudinal Analysis of the Mexican Health and Aging Study.Vitamin D deficiency in older adults and its associated factors: a cross-sectional analysis of the Mexican Health and Aging Study.Diabetes mellitus, hypertension and frailty: A population-based, cross-sectional study of Mexican older adults.Predictive Value of Frailty Indices for Adverse Outcomes in Older Adults.The Coyoacán Cohort Study: Design, Methodology, and Participants' Characteristics of a Mexican Study on Nutritional and Psychosocial Markers of Frailty.The geriatric management of frailty as paradigm of "The end of the disease era".How the Frailty Index May Support the Allocation of Health Care Resources: An Example From the INCUR Study.Frailty Across Age Groups.Association of Healthy Habits Beliefs and Mortality in Older Adults: A Longitudinal Analysis of the Mexican Health and Aging Study.Sarcopenia and post-hospital outcomes in older adults: A longitudinal study.Frailty and food insecurity in older adults.Lack of Energy and Negative Health-Related Outcomes in Nursing Home Residents: Results From the INCUR Study.Sarcopenia prevalence.The Chimeric Nihilism of Geriatrics.Edentulism and its relationship with self-rated health: secondary analysis of the SABE Ecuador 2009 Study.TWO-WAY Bridge between Muscular Dysfunction and Cognitive Impairment: Secondary Analyses of SABE - Bogota Study.Frailty, diabetes, and the convergence of chronic disease in an age-related condition: a population-based nationwide cross-sectional analysis of the Mexican nutrition and health survey.Psychometric evaluation of a Spanish language version of the Screen for Caregiver Burden (SCB) in caregivers of patients with mixed, vascular and Alzheimer's dementia.[Fragility is not associated with a low frequency of vaccination in older adults].Performance of the European Working Group on Sarcopenia in Older People algorithm in screening older adults for muscle mass assessment.Sensor Augmented Insulin Pump Therapy in Older Adults: Impact on Self-Rated Health and Glycemic Control.Frailty and Multimorbidity: Different Ways of Thinking About Geriatrics.Letter to the Editor: Frailty and Cognition: Not as Straightforward as It Might Appear.Mortality and associated risk factors for older adults admitted to the emergency department: a hospital cohort.Socioeconomic inequalities in frailty among older adults in six low- and middle-income countries: Results from the WHO Study on global AGEing and adult health (SAGE)
P50
Q33610493-97A12B37-8CDB-4B67-B984-13E32C308AC9Q33630973-521275A1-26AC-46A0-A8EC-73242EC0AE0CQ33873174-CB2F3BFE-983A-4202-82D8-323852621A1BQ34580481-298C397C-6D19-46F5-AAFF-C409E611C106Q34921402-E187645A-0B64-44BB-AF8F-ECFD8530EC19Q34927658-C7A7BDD2-DE8D-4B98-984F-5AA229808BF5Q35992538-FF2233CC-94A0-4AD3-9725-67FECDAB29F5Q36581897-DF0E280B-1FA4-4408-B446-6AEE6346D9C6Q36609022-240F6BCB-5570-42C0-A399-BE06CD90F183Q37138299-8D8F0D37-1D72-4F34-BFFF-FD0409FA99C9Q37138558-E294D923-4F2B-4EAC-91CD-E75D3AB05365Q37230846-6BB01804-FF29-4A62-9E54-AC1D77424F65Q37265782-25A75EB0-ECFD-4D05-A48A-185AB92126F1Q38268458-3A044653-5EC4-4A0D-8A95-76DD33AB7ECCQ38550439-5F306072-2C9B-43FD-8050-BEFC8DF0BC35Q38937655-B2404277-E4C0-44C3-8771-2280010AB4BCQ39061275-4E80CA62-2D04-42AA-B8DC-7E8F9824A764Q39714580-718B809E-BC6C-4E37-88E3-7F01FA2C4F1AQ39831900-44FF19D8-DEB3-4365-A817-1D35A02C4203Q39857274-476E2E02-9814-46E7-9092-DCCD00A76E3FQ39903224-678901DC-C29C-4BE3-AFB4-CD8FD69B19ECQ39905020-3710F2F3-1AAA-4EB2-8518-71F5EF8A1934Q39918134-7E0796B8-DF3B-4B34-95B4-EBB5736A7A83Q40134369-0E80C6B4-1C20-4901-A2B8-0C41896AAE37Q40443570-5D26A188-1097-4A32-B26E-66E32D01EA6FQ40773724-63639976-490B-410C-A92A-2A7BF7E2DD5BQ40858043-C7128350-20CC-41D6-92A0-0B518B62A3C1Q45366801-8DC5188A-B99C-4454-8001-FE6F2AEDFA08Q46041963-7DA4E0CD-0517-4279-B221-27A5AAC2151DQ47296330-3189AA66-61F6-4F77-A5B9-C6F7AF724E14Q47665549-978C565F-D6C9-4D2C-8E68-FBE89361539DQ48225753-46E64EE7-8B88-4604-8E5E-ACF35D04CF16Q48303509-1243CD34-95A7-4A83-A127-CB0956380942Q50051417-0C391DE9-29C4-4785-99AC-1BE6E07AB545Q50989932-2E217639-66F5-4AB1-AFA5-6F4553EA345FQ51827266-3A6BDD74-65D3-4D8C-B5EC-79BC07607749Q51836603-BB484ABB-C429-4077-825F-30172D24DE15Q53809062-60F60275-2772-47C7-85BD-AB248F21A75AQ55398523-4FA55805-5152-4C71-8B24-53E71D68B9F1Q58880621-8192CDC9-3184-4BAD-A212-654ECA6EF734
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Mario U Pérez-Zepeda
@ast
Mario U Pérez-Zepeda
@en
Mario U Pérez-Zepeda
@es
Mario U Pérez-Zepeda
@nl
type
label
Mario U Pérez-Zepeda
@ast
Mario U Pérez-Zepeda
@en
Mario U Pérez-Zepeda
@es
Mario U Pérez-Zepeda
@nl
prefLabel
Mario U Pérez-Zepeda
@ast
Mario U Pérez-Zepeda
@en
Mario U Pérez-Zepeda
@es
Mario U Pérez-Zepeda
@nl
P106
P1153
37124701800
P31
P496
0000-0003-4374-976X